Hepatitis B surface antigen and hepatitis B RNA changes in HIV/hepatitis B virus co-infected participants receiving hepatitis B virus-active antiretroviral therapy-Reference-Cited by-同舟云学术

Hepatitis B surface antigen and hepatitis B RNA changes in HIV/hepatitis B virus co-infected participants receiving hepatitis B virus-active antiretroviral therapy

Published:2022-02-14 Issue:7 Volume:36 Page:975-984
ISSN:0269-9370
Container-title:AIDS
language:en
Short-container-title:

Author:

Hawkins Claudia,Kang Minhee,Bhattacharya Debika,Cloherty Gavin,Kuhns Mary,Matining Roy,Thio Chloe,Samaneka Wadzanai,Chinula Lameck,Mulinda Nyirenda,Badal-Faesen Sharlaa,Sugandhavesa Patcharaphan,Lama Javier,Gaseitsiwe Simani,Holzmayer Vera,Anderson Mark,Murphy Robert,Peters Marion

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference44 articles.

1. Epidemiology and impact of HIV coinfection with hepatitis B and hepatitis C viruses in sub-Saharan Africa;Matthews;J Clin Virol,2014

2. HIV-hepatitis B virus coinfection: epidemiology, pathogenesis, and treatment;Singh;AIDS,2017

3. Insights for clinical diagnostic indicators of virus and host in chronic hepatitis B infection;Ou;J Viral Hepat,2020

4. Serum hepatitis B surface antigen and hepatitis B e antigen titers: disease phase influences correlation with viral load and intrahepatic hepatitis B virus markers;Thompson;Hepatology,2010

5. Serum HBV pgRNA as a clinical marker for cccDNA activity;Giersch;J Hepatol,2017

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Measuring HBV pregenomic RNA may be a potential biomarker to determine HBV functional cure in HIV/HBV‐co‐infected patients with HBsAg loss;Journal of Medical Virology;2024-06

2. Circulating HBV RNA and Hepatitis B Core–Related Antigen Trajectories in Persons With HIV/HBV Coinfection and Hepatitis B Surface Antigen Loss During Tenofovir Therapy;The Journal of Infectious Diseases;2024-04-16

3. Design and analysis considerations for early phase clinical trials in hepatitis B (HBV) cure research: the ACTG A5394 study in persons with both HIV and HBV;Journal of Virus Eradication;2023-09

4. HIV-HBV Coinfection—Current Challenges for Virologic Monitoring;Biomedicines;2023-04-28

5. Measuring hepatitis B pgRNA stability using an updated automated HBV pgRNA assay with increased sensitivity;Hepatology Communications;2023-03-17